Abstract
Pelvic Organ Prolapse (POP) is the downward descent of pelvic organs into the vagina and affects more than 25% of all women. Despite the broad acceptance of synthetic mesh surgery for treating POP, complications led to FDA warnings. Tissue engineering using mesenchymal stem cells to modulate the tissue response could reduce these complications. I assessed the immunomodulatory effect of human endometrial mesenchymal stem cells (eMSC) on the macrophage response to polyamide/gelatin composite mesh in immunocompetent and immunocompromised mice. eMSC dampen the macrophage-mediated inflammatory response against implanted mesh. eMSC exerted their modulatory effects via paracrine factor secretion influencing all types of innate and adaptive immune cells in immunocompetent mice and only macrophages in immunocompromised mice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
